INTELLIGENT BIO SOLUTIONS INC. Number of Reportable Segments
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Number of Reportable Segments of 2 Integer for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2025-05-13
- 2025-03-31: Number of Reportable Segments 9 month 2.00 Integer.
- 2024-12-31: Number of Reportable Segments 6 month 2.00 Integer.
| Period end | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month |
|---|---|---|
| 2025-03-31 | 2.00 Integer 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 2.00 Integer 10-Q · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |